Condition

Immune-Related Adverse Events clinical trials and research

• 8Clinical trials
• 6Countries

Newest Immune-Related Adverse Events clinical trials

All recruiting trials (8)

• Rituximab for treating immune-related side effects from checkpoint inhibitors

  This small early-phase trial tests whether a single 100 mg dose of rituximab can help manage immune-related adverse events in adults with malignant melanoma who are on checkpoint inhibitors, alongside a tapering corticosteroid plan.

  Recruiting Phase 1 Herlev Hospital · Herlev, Herlev · NCT07694414

• Immune-related side effects from cancer immunotherapy and whether it's safe to restart treatment

  This project will see if restarting immune checkpoint drugs after immune-related side effects is safe for adults with cancer who had those side effects.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07453342

• Adebrelimab plus platinum chemotherapy before surgery for operable esophageal squamous cell carcinoma

  This trial will try giving adebrelimab with platinum-based chemotherapy before surgery in people with locally advanced, resectable esophageal squamous cell carcinoma to see if it increases complete tumor disappearance and is safe.

  Recruiting The Second Hospital of Shandong University · Jinan · NCT07430579

• Tracking immune-related side effects in people with solid tumors starting immunotherapy

  We will follow adults with solid tumors beginning immune checkpoint inhibitors to see if blood, tissue, and other tests can predict or explain immune-related side effects, with special attention to neurological problems.

  Recruiting at 6 sites Shantou University Medical College · Fuzhou, Fujian and 5 other locations · NCT07357636

• Interferon patterns in cancer patients receiving CTLA-4 or PD-1/PD-L1 inhibitors versus autoimmune disease

  This project will test whether blood interferon levels can help predict immune-related side effects in adults starting checkpoint inhibitor immunotherapy by comparing them with people who have autoimmune diseases.

  Recruiting Hospital Universitario Araba · Pamplona, Navarre · NCT07249060

• Low-dose prednisolone for immune checkpoint inhibitor–related hepatitis

  This project will try low-dose prednisolone (0.5–1 mg/kg) to manage grade 2–3 immune-related hepatitis in adults receiving immune checkpoint inhibitors.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City and 1 other locations · NCT07167251

• Informatics-assisted detection of immune-related side effects to improve biorepository enrollment

  This project tests whether an automated system that reads electronic health records can help identify cancer patients on immunotherapy who are having immune-related side effects so they can be enrolled in a biorepository.

  Recruiting at 2 sites Phase 1/2 Brigham and Women's Hospital · Boston, Massachusetts and 1 other locations · NCT06789601

• Monitoring the safety of Sintilimab in Chinese patients

  This study is testing how safe Sintilimab is for Chinese patients by closely watching for any side effects while they receive the treatment.

  Recruiting Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing, Beijing Municipality · NCT04840355

Related topics

Quick answers

How many Immune-Related Adverse Events clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in China (4 trials), Spain (1 trial), Switzerland (1 trial), United Kingdom (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →